[Solved] Bladder and ketamine

Ketamine can be harmful to the bladder, especially with frequent or prolonged recreational use. This is known as ketamine-induced cystitis or ketamine bladder syndrome. The main effects on the bladder are:

1. Inflammation of the bladder wall: Ketamine irritates the bladder wall, leading to chronic inflammation (cystitis).

2. Loss of bladder capacity: Due to the inflammation and scarring, the bladder shrinks, causing you to urinate more frequently.

3. Pain and burning sensation: Many users experience pain in the lower abdomen, especially during urination.

4. Urinary incontinence: Due to reduced bladder control, involuntary urine loss may occur.

5. Blood in the urine (hematuria): In severe cases, the bladder wall is damaged to such an extent that blood is released.

6. Damage to the urinary tract and kidneys: If the bladder no longer functions properly, pressure can build up into the kidneys, leading to kidney damage.

With occasional use of ketamine, the risks of bladder damage are minimal, but ketamine can be addictive and chronic use can cause damage.

Chronic recreational use of ketamine can lead to ketamine-associated uropathy (KU), in which not only the bladder but the entire urinary system can be affected.. The typical symptoms include frequent urination, urgency, dysuria, hematuria, pain, and a severely reduced bladder capacity. . Pathophysiologically, direct cytotoxic effects on the urothelium, inflammation, apoptosis, and fibrosis caused by ketamine and its metabolites play a central role.. Early recognition, discontinuation of ketamine, and conservative treatment methods can often lead to improvement, while severe cases require surgical intervention.

What is ketamine-associated uropathy?

Ketamine-associated uropathy (KU) is the term for the damage that ketamine (and its metabolites) can cause to the urinary tract.. Although it is sometimes referred to as 'ketamine cystitis' or 'ketamine bladder syndrome', the damage is not limited to the bladder but can extend to the kidneys..

Pathophysiology

The damage is caused by multiple, partially overlapping mechanisms. First, direct cytotoxic effects occur on the urothelium, resulting in reduced expression of junction proteins and disruption of the barrier function in the bladder wall.. In addition, ketamine-induced neurogenic and IgE-mediated inflammation leads to further tissue damage, followed by apoptosis and fibrosis of the bladder substance. . This culminates in ulcerative changes and reduced elastic capacity, which can drastically decrease bladder capacity.

Clinical presentation

Patients often report:

• Lower urinary tract complaints such as frequency, urgency, nocturia, dysuria, and urge incontinence.
• Hematuria and suprapubic pain upon bladder filling.
• Reduced bladder capacity, sometimes to less than 10 % of the normal content, and pain with small volumes .
• In severe cases, vesicoureteral reflux, papillary necrosis and kidney dysfunction
  

Epidemiology

The prevalence of ketamine use among young people has increased in recent years: in the UK, the share of users rose from 0.5 % (2010) to 0.8 % (2020), and among 16- to 24-year-olds from 1.7 % to 3.2 %. In Taiwan, a survey of 106 ketamine users found that the average time to first lower urinary tract symptoms was 24.7 ± 26.4 months.. According to an American survey, 26.6% of recent ketamine users reported at least one symptom of ketamine cystitis..

Diagnostics

Diagnostic examination includes:

1. Anamnesis, including specifically asking about recreational ketamine use (PMC, NCBI).

2. Urine test, usually sterile but sometimes with erythrocytes or inflammatory cells.

3. Cystoscopy, with characteristic findings such as neovascularization, ulcerations, and erythematous wall changes.

4. Imaging (ultrasound, CT/MRI) to map bladder capacity, wall thickening, and upper urinary tract damage.

Treatment and prevention

• Ketamine abstinence is the cornerstone; upon stopping, symptoms improve in the majority of patients..
• Conservative therapy Oral medication (anticholinergics, NSAIDs) or intravesical therapy (hyaluronic acid, alkaline rinses) can provide symptomatic relief..
• Bladder hydrodilation can temporarily increase bladder capacity, but recurrence is common if use is not stopped.
• Surgical procedures procedures such as enterocystoplasty or cystectomy with enterocystoplasty are reserved for patients with irreversible damage and life-threatening reflux or renal insufficiency..

Conclusion

With chronic recreational use, ketamine is clearly harmful to the bladder and the entire urinary system. Early recognition, discontinuation of ketamine, and targeted treatment are crucial to prevent progressive tissue damage, permanent loss of function, and major surgical interventions.

Never use ketamine! You will become addicted to it, and it will ruin your bladder and kidneys!